-+ 0.00%
-+ 0.00%
-+ 0.00%

IntegraGen receives two takeover bids in court-supervised restructuring process

PUBT·09/11/2026 18:40:26
Listen to the news
IntegraGen receives two takeover bids in court-supervised restructuring process
  • IntegraGen received two takeover bids under its court-supervised restructuring, submitted by Health In Code, ABL Diagnostics.
  • Proposals target selected operations, assets via a sale plan. Both bidders plan to fund the transaction from internal resources.
  • Bids exclude any purchase of IntegraGen shares, leaving equity holders exposed to a potential total loss.
  • Commercial court in Évry is set to rule on a sale plan on Oct. 5, 2026.
  • Company flagged potential delisting from Euronext Growth Paris.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IntegraGen SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260911943938) on September 11, 2026, and is solely responsible for the information contained therein.